| AC | Adjuvant Chemotherapy |
| AE(s) | Adverse Event(s) |
| BMI | Body Mass Index |
| BTC | Biliary Tract Cancer |
| BW | Body Weight |
| CAR | C-reactive Protein-to-Albumin Ratio |
| ESPEN | European Society for Clinical Nutrition and Metabolism |
| GLIM | Global Leadership Initiative on Malnutrition |
| GNRI | Geriatric Nutritional Risk Index |
| GRADE | Grading of Recommendations, Assessment, Development and Evaluations |
| HDAC | Histone deacetylase |
| IL-6 | interleukin-6 |
| JAK | Janus kinase |
| NAC | Neoadjuvant Chemotherapy |
| NCCN | National Comprehensive Cancer Network |
| NF-κB | nuclear factor-κB |
| OCEBM | Oxford Centre for Evidence-Based Medicine |
| ONS(s) | Oral Nutritional Supplement(s) |
| OS | Overall Survival |
| PC | Pancreatic Cancer |
| PEI | Pancreatic Exocrine Insufficiency |
| PERT | Pancreatic Enzyme Replacement Therapy |
| PNI | Prognostic Nutritional Index |
| POC | Postoperative Complication |
| RDI | Relative Dose Intensity |
| SCFA | short-chain fatty acid |
| SMI | skeletal muscle index |
| STAT3 | signal transducer and activator of transcription 3 |
| TNF-α | tumor necrosis factor-α |